Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
about
MICEST: a potential tool for non-invasive detection of molecular changes in Alzheimer's diseaseMagnetic resonance spectroscopy in common dementiasAdvances in high-field magnetic resonance spectroscopy in Alzheimer's diseaseVarious MRS application tools for Alzheimer disease and mild cognitive impairment.What have novel imaging techniques revealed about metabolism in the aging brain?Intramyocellular lipid quantification: comparison between 3.0- and 1.5-T (1)H-MRSN-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T.Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy.N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathologyShort echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point studyApplications of multi-nuclear magnetic resonance spectroscopy at 7T.Brain metabolic correlates of decision making in amnestic mild cognitive impairment.Global N-acetylaspartate in normal subjects, mild cognitive impairment and Alzheimer's disease patients.Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patientsImproved localization, spectral quality, and repeatability with advanced MRS methodology in the clinical setting.Imaging of glutamate neurotransmitter alterations in Alzheimer's disease.Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there?Comparison of 1.5T and 3T 1H MR spectroscopy for human brain tumorsRegional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies.Improved quantification precision of human brain short echo-time (1) H magnetic resonance spectroscopy at high magnetic field: a simulation study.On the voxel size and magnetic field strength dependence of spectral resolution in magnetic resonance spectroscopy.Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.Mini-Mental State Examination and proton spectroscopy of the posterior cingulate in Alzheimer disease.Energetics of Excitatory and Inhibitory Neurotransmission in Aluminum Chloride Model of Alzheimer's Disease: Reversal of Behavioral and Metabolic Deficits by Rasa Sindoor.Elevated Choline-Containing Compound Levels in Rapid Cycling Bipolar Disorder.
P2860
Q30572242-5A775140-90B9-4187-8EEF-9B94DF32E52DQ30660402-06067011-A80D-46FE-8365-163A6D0E4C38Q30770751-411A9168-DB7F-4263-99B2-780E4D37DF31Q30803093-C2799412-72D8-48F2-9668-A3A0EEAF7583Q30850844-DF87B05D-46EB-4A9A-938E-FD224909F300Q31122114-984094E8-920B-47D5-95AE-E38F865A40A4Q33271816-F6DC793B-78F3-4896-A9F8-FDF2EAA5AFB3Q33745500-8DBD0D59-04C5-45CA-8F34-DAF027984077Q33920295-01BF3FEC-AB46-41D7-9403-36EAABBBCF52Q34029600-5389A748-772C-4C59-ACAD-1766E2B9E760Q34125535-D7EF3C8A-EF64-4A9C-9C0C-8021740C925CQ34247831-A026ABB0-CAD8-438D-9A04-A9C2F8CEC1D6Q34885076-B9808E64-FEDF-4FCD-A090-413872BD037CQ35097548-00F688E0-D191-4753-8D48-83E5A607DF47Q35653396-C3604775-99D3-4298-AAC9-9771C6E20127Q35749809-E33A88D5-2899-4C6A-8BEE-824941CB8439Q36406445-EAE95990-DA3F-49C0-B38C-149599B356AAQ36565888-DC13FC1B-79AB-4881-B272-A62A23AF07CAQ36607324-29E48302-E61D-48C7-8362-6EBA6B5EE9EEQ37155046-CC026B0C-5054-4D4D-8FB7-21160C89C255Q37652823-38E5A066-D11E-4952-996C-3AD981817616Q41901287-BF532DE7-258E-4FB1-A318-F63443BA9E18Q43152090-F888F7C0-D2D3-4D8A-A8AA-2B3D04A49533Q44937365-4B329DD8-C7AC-4491-9F27-9685204348C0Q45905949-FA326F9D-3423-4497-8E59-ECE2CCF593ABQ47167624-915BA332-9A2F-4666-BDB2-03C6C7963813Q53656292-F8D06A99-238D-44C1-B1AD-D12FFBC6ED6E
P2860
Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Proton MR spectroscopy in mild ...... se: comparison of 1.5 and 3 T.
@en
Proton MR spectroscopy in mild ...... se: comparison of 1.5 and 3 T.
@nl
type
label
Proton MR spectroscopy in mild ...... se: comparison of 1.5 and 3 T.
@en
Proton MR spectroscopy in mild ...... se: comparison of 1.5 and 3 T.
@nl
prefLabel
Proton MR spectroscopy in mild ...... se: comparison of 1.5 and 3 T.
@en
Proton MR spectroscopy in mild ...... se: comparison of 1.5 and 3 T.
@nl
P2093
P50
P1476
Proton MR spectroscopy in mild ...... se: comparison of 1.5 and 3 T.
@en
P2093
Bradley F Boeve
Eric G Tangalos
Glenn E Smith
Glenn Reynolds
Robert J Ivnik
Steven D Edland
P304
P577
2003-05-01T00:00:00Z